Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quinsam Capital is a Canadian merchant bank that specializes in the small-cap market, providing funding and advisory services to early-stage companies. The firm is well-known for its significant historical focus on the cannabis sector, though it has since diversified into other areas including technology and healthcare. Quinsam operates by investing its own capital in undervalued companies through various structures such as equity, warrants, and bridge loans. As a public entity, it offers investors exposure to a diversified portfolio of private and small-cap public companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quinsam Capital.